Ligands for the GABAA receptor complex

Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology

Volumn , Issue , 2001, Pages 236-274

  Krogsgaard Larsen, Povl ^a   Frølund, Bente ^a   Kristiansen, Uffe ^a   Ebert, Bjarke ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862431049     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (220)

1. A antagonists’, Aust. J. Chem. 43: 1767-1772.
2. Arnt, J. and Krogsgaard-Larsen, P. (1979) ‘GABA agonists and potential antagonists related to muscimol’, Brain Res. 177: 395-400.
3. Barnard, E.A. (1992) ‘Receptor classes and the transmitter-gated ion channels’, Trends Biochem. Sci. 17: 368-374.
4. Barnard, E.A. and Costa, E. (eds) (1989) Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications, New York: Raven Press.
5. Baulieu, E.E. (1991) ‘Neurosteroids: a new function in the brain’, Biol. Cell. 71: 3-10.
6. Belhage, B., Damgaard, I., Saederup, E., Squires, R.F. and Schousboe, A. (1991) ‘High- and lowaffinity GABA-receptors in cultured cerebellar granule cells regulate transmitter release by different mechanisms’, Neurochem. Intl. 19: 475-482.
7. Belhage, B., Hansen, G.H., Meier, E. and Schousboe, A. (1990) ‘Effects of inhibitors of protein synthesis and intracellular transport on the GABA-agonist induced functional differentiation of cultured cerebellar granule cells’, J. Neurochem. 55: 1107-1113.
8. Benes, F.M., Vincent, S.L., Alsterberg, G., Bird, E.D. and SanGiovanni, J.P. (1992) ‘Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics’, J. Neurosci. 12: 924-929.
9. Biggio, G. and Costa, E. (eds) (1990) GABA and Benzodiazepine Receptor Subtypes, New York: Raven Press.
10. Bixler, E.O., Kales, A., Brubaker, B.H. and Kales, J.D. (1987) ‘Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system’, Pharmacology 35: 286-300.
11. Bouchet, M.-J., Jacques, P., Ilien, B., Goeldner, M. and Hirth, C. (1992) ‘m-sulfonate benzene diazonium chloride: a powerful affinity label for the γ-aminobutyric acid binding site from rat brain’, J. Neurochem. 59: 1405-1413.
12. Boue-Grabot, E., Roudbaraki, M., Tramu, G., Block, B. and Garret, M. (1998) ‘Expression of GABA receptor p subunits in rat brain’, J. Neurochem. 70: 899-907.
13. Bowery, N.G. (1983) ‘Classification of GABA receptors’, in S.J. Enna (ed.) The GABA Receptors, Clifton: The Humana Press, pp. 177-213.
14. B Receptors in Mammalian Function, Chichester: John Wiley.
15. Bowery, N.G., Hill, D.R., Hudson, A.L., Doble, A., Middlemiss, D.N., Shaw, J. and Turnbull, M. (1980) '(-) baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor’, Nature 283: 92-94.
16. Bowery, N.G. and Nistico, G. (eds) (1989) GABA: Basic Research and Clinical Applications, Rome: Pythagora Press.
17. Braestrup, C., Nielsen, M., Krogsgaard-Larsen, P. and Falch, E. (1979) ‘Partial agonists for brain GABA/benzodiazepine receptor complex’, Nature 280: 331-333.
18. A receptors’, Eur. J. Med. Chem. 32: 357-363.
19. Brioni, J.D., Decker, M.W., Gamboa, L.P., Izquierdo, I. and McGaugh, J.L. (1990) ‘Muscimol injections in the medial septum impair spatial learning’, Brain Res. 522: 227-234.
20. Brioni, J.D., Nagahara, A.H. and McGaugh, J.L. (1989) ‘Involvement of the amygdala GABAergic system in the modulation of memory storage’, Brain Res. 487: 105-112.
21. Brodie, M.J. and McKee, P.J.W. (1990) ‘Vigabatrin and psychosis’, Lancet 335: 1279.
22. Bruno, G., Foster, N.L., Fedio, P., Mohr, E., Cox, C., Gillespie, M.M. and Chase, T.N. (1984) ‘THIP therapy of Alzheimer’s disease’, Neurology Suppl. 34: 225.
23. Bureau, M. and Olsen, R.W. (1990) ‘Multiple distinct subunits of the γ-aminobutyric acid-A receptor protein show different ligand-binding affinities’, Mol. Pharmacol. 37: 497-502.
24. Burke, D., Andrews, C.J. and Knowles, L. (1971) ‘The action of a GABA derivative in human spasticity’, J. Neurol. 14: 199-208.
25. A agonist, THIP’, Drug Des. Delivery 10: 213-229.
26. Byberg, J.R., Labouta, I.M., Falch, E., Hjeds, H., Krogsgaard-Larsen, P., Curtis, D.R. and Gynther, B.D. (1987) ‘Synthesis and biological activity of a GABA-A agonist which has no effect on benzodiazepine binding and structurally related glycine antagonists’, Drug Des. Delivery 1: 261-274.
27. Caspary, D.M., Raza, A., Lawhorn Armour, B.A., Pippin, J. and Arneri, S.P. (1990) ‘Immunocytochemical and neurochemical evidence for age-related loss of GABA in the inferior colliculus: implications for neural presbycusis’, J. Neurosci. 10: 2363-2372.
28. A receptor with [3H]muscimol’, J. Neurochem. 44: 916-921.
29. Chambon, J.-P., Feltz, P., Heaulme, M., Restlé, S., Schlichter, R., Biziére, K. and Wermuth, C.G. (1985) ‘An arylaminopyridazine derivative of -γ-aminobutyric acid (GABA) is a selective and competitive antagonist of the receptor sites’, Proc. Natl. Acad. Sci. USA 82: 1832-1836.
30. Cherubini, E., Gaiarsa, J.L. and Ben-Ari, Y. (1991) ‘GABA: an excitatory transmitter in early postnatal life’, Trends Neurosci. 14: 515-519.
31. Curtis, D.R., Duggan, A.W., Felix, D. and Johnston, G.A.R. (1970) ‘GABA, bicuculline and central inhibition’, Nature 226: 1222-1224.
32. Curtis, D.R., Game, C.J.A., Johnston, G.A.R. and McCulloch, R.M. (1974) ‘Central effects of β-(pchlorophenyl)-γ-aminobutyric acid’, Brain Res. 70: 493-499.
33. Curtis, D.R. and Johnston, G.A.R. (1974) ‘Amino acid transmitters in the mammalian central nervous system’, Ergebn. Physiol. 69: 97-188.
34. 1 cDNA: a GABA receptor subunit highly expressed in retina’, Proc. Natl. Acad. Sci. USA 88: 2673-2677.
35. Dannhardt, G., Dominiak, P. and Laufer, S. (1993) ‘Hypertensive effects and structure-activity relationships of 5-ω-aminoalkyl isoxazoles’, Drug Res. 43: 441-444.
36. A receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex’, J. Neurochem. 72: 1593-1599.
37. B receptors potentiates the depolarization induced increase of intraneuronal ionised calcium content in cerebellar granule neurons’, Mol. Pharmacol. 42: 407-414.
38. DeFeudis, F.V. (1989) ‘GABA agonists and analgesia’, Drug News Perspect. 2: 172-173.
39. A receptor structure and function’, J. Biol. Chem. 267: 16,747-16,750.
40. DiChiara, G. and Gessa, G.L. (eds) (1981) GABA and the Basal Ganglia, New York: Raven Press.
41. Djamgoz, M.B.A. (1995) ‘Diversity of GABA receptors in the vertebrate outer retina’, Trends Neurosci. 18: 118-120.
42. A/Benzodiazepine Receptor as a Target for Psychoactive Drugs, Heidelberg: Springer.
43. Drew, C.A. and Johnston, G.A.R. (1992) ‘Bicuculline- and baclofen-insensitive -γ-aminobutyric acid binding to rat cerebellar membranes’, J. Neurochem. 58: 1087-1092.
44. 13H]thiomuscimol’, Neurochem. Intl. 34: 427-434.
45. Ebert, B., Thompson, S.A., Saounatsou, K., McKernan, R., Krogsgaard-Larsen, P. and Wafford, K.A. (1997) ‘Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human -γ-aminobutyric acid type A receptors’, Mol. Pharmacol. 52: 1150-1156.
46. Ebert, B., Wafford, K.A., Whiting, P.J., Krogsgaard-Larsen, P. and Kemp, J.A. (1994) ‘Molecular pharmacology of -γ-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different α, β and -γ receptor subunit combinations’, Mol. Pharmacol. 46: 957-963.
47. Edvinsson, L., Larsson, B. and Skärby, T. (1980) ‘Effect of the GABA receptor agonist muscimol on regional cerebral blood flow in the rat’, Brain Res. 185: 445-448.
48. Erdö, S.L. (1985) ‘Peripheral GABAergic mechanisms’, Trends Pharmacol. Sci. 6: 205-208.
49. Erdö, S.L. and Bowery, N.G. (eds) (1986) GABAergic Mechanisms in Mammalian Periphery, New York: Raven Press.
50. B receptor sites and GABA uptake using rat brain membrane preparations’, J. Neurochem. 47: 898-903.
51. Falch, E., Jacobsen, P., Krogsgaard-Larsen, P., Curtis, D.R. (1985) ‘GABA-mimetic activity and effects on diazepam binding of aminosulphonic acids structurally related to piperidine-4-sulphonic acid’, J. Neurochem. 44: 68-75.
52. Falch, E., Larsson, O.M., Schousboe, A. and Krogsgaard-Larsen, P. (1990) ‘GABA-A agonists and GABA uptake inhibitors: structure-activity relationships’, Drug Dev. Res. 21: 169-188.
53. Fariello, R.G., Morselli, P.L., Lloyd, K.G., Quesney, L.F. and Engel, J. (eds) (1984) Neurotransmitters, Seizures, and Epilepsy II, New York: Raven Press.
54. − channels in rat retinal bipolar cells’, Nature 361: 159-162.
55. Foster, N.L., Chase, T.N., Denaro, A., Hare, T.A. and Tamminga, C.A. (1983) ‘THIP treatment and Huntington’s chorea’, Neurology 33: 637-639.
56. Friedman, D.E. and Redburn, D.A. (1990) ‘Evidence for functionally distinct subclasses of -γ-aminobutyric acid receptors in rabbit retina’, J. Neurochem. 55: 1189-1199.
57. B agonists’, J. Med. Chem. 38: 3297-3312.
58. B antagonists’, J. Med. Chem. 38: 3313-3331.
59. B antagonists: resolution, absolute stereochemistry and pharmacology of (R)- and (S)-phaclofen’, Chirality 6: 583-589.
60. A agonist photoaffinity label’, J. Labelled Compd. Radiopharm. 36: 877-889.
61. A agonists: resolution and pharmacology of (+)- and (-)-isoguvacine oxide’, Chirality 7: 434-438.
62. A receptor agonists. Synthesis and in vitro pharmacology of a series of nonannulated analogs of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol’, J. Med. Chem. 38: 3287-3296.
63. A agonist’, in A. Schousboe, N.H. Diemer and H. Kofod (eds) Drug Research Related to Neuroactive Amino Acids, Alfred Benzon Symposium 32: Copenhagen: Munksgaard, pp. 449-460.
64. Gammill, R.B. and Carter, D.B. (1993) ‘Neuronal BZD receptors: new ligands, clones and pharmacology’, Annu. Rep. Med. Chem. 28: 19-27.
65. Gasior, M., Carter, R.B. and Witkin, J.M. (1999) ‘Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders’, Trends Pharmacol. Sci. 20: 107-112.
66. A receptor’, Neurosci. Facts, 3: 71-72.
67. Haefely, W. (1984) ‘Pharmacological profile of two benzodiazepine partial agonists: Ro 16-6028 and Ro 17-1812', Clin. Neuropharmacol. 7(suppl. 1):670-671.
68. Haefely, W. and Polc, P. (1986) ‘Physiology of GABA enhancement by benzodiazepines and barbiturates’, in R.W. Olsen and J.C. Venter (eds) Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, New York: Alan R. Liss, pp. 97-133.
69. A receptors’, FASEB J. 5: 2466-2472.
70. Hall, R.C. and Zisool, S. (1981) ‘Paradoxical reactions to benzodiazepines’, Br. J. Clin. Pharmacol. 11: 99S-104S.
71. 3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics’, Life Sci. 40: 259-266.
72. A-receptors and voltage sensitive calcium channels’, Neurosci. Lett. 137: 14-18.
73. Harrison, N.L. and Simmonds, M.A. (1984) ‘Modulation of the GABA receptor complex by a steroid anaesthetic’, Brain Res. 323: 287-292.
74. Hoehn-Saric, R. (1983) ‘Effects of THIP on chronic anxiety’, Psychopharmacology 80: 338-341.
75. Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E.P., Cumin, R., Schaffner, R. and Haefely, W. (1981) ‘Selective antagonists of benzodiazepines’, Nature 290: 514-516.
76. Huston, E., Gullen, G., Sweeney, M.I., Pearson, H., Fazeli, M.S. and Dolphin, A.C. (1993) ‘Pertussis toxin treatment increases glutamate release and dihydropyridine binding sites in cultured rat cerebellar granule neurons’, Neuroscience 52: 787-798.
77. B agonists and antagonists in transmitter release and somatic calcium currents in cultured neurons’, Neuroscience 38: 721-729.
78. A ligands of dual functionality’, J. Med. Chem. 42: 1123-1144.
79. Johnston, G.A.R. (1986) ‘Multiplicity of GABA receptors’, in R.W. Olsen and J.C. Venter (eds) Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, New York: Alan R. Liss, pp. 57-71.
80. A receptor pharmacology’, Pharmacol. Ther. 69: 173-198.
81. C receptors: molecular biology, pharmacology and physiology’, in S.J. Enna and N.G. Bowery (eds) The GABA Receptors, Totowa: The Humana Press, pp. 297-323.
82. Johnston, G.A.R., Beart, P.M., Curtis, D.R., Game, C.J.A., McCulloch, R.M. and MacLachlan, R.M. (1972) ‘Bicuculline methochloride as a GABA antagonist’, Nature (New Biol.) 240: 219-220.
83. Johnston, G.A.R., Curtis, D.R., Beart, P.M., Game, C.J.A., McCulloch, R.M. and Twitchin, B. (1975a) ‘Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation’, J. Neurochem. 24: 157-160.
84. Johnston, G.A.R., Krogsgaard-Larsen, P. and Stephanson, A. (1975b) ‘Betel nut constituents as inhibitors of -γ-aminobutyric acid uptake’, Nature 258: 627-628.
85. Kardos, J. (1999) ‘Recent advances in GABA research’, Neurochem. Intl. 34: 353-358.
86. B receptors in regulation of transmitter release in cerebellar granule neurons’, J. Neurosci. Res. 39: 646-655.
87. Kehler, J., Stensbøl, T.B. and Krogsgaard-Larsen, P. (1999) ‘Piperidinyl-3-phosphinic acids as novel uptake inhibitors of the neurotransmitter 4-aminobutyric acid (GABA)', Bioorg. Med. Chem. Lett. 9: 811-814.
88. Kendall, D.A., Browner, M. and Enna, S.J. (1982) ‘Comparison of the antinociceptive effect of GABA agonists: evidence for a cholinergic involvement’, J. Pharmacol. Exp. Ther. 220: 482-487.
89. B-receptors in peripheral function’, in S.L. Erdö and N.G. Bowery (eds) GABAergic Mechanisms in Mammalian Periphery, New York: Raven Press, pp. 239-259.
90. Kerr, D.I.B., Ong, J., Prager, R.H., Gynther, B.D. and Curtis, D.R. (1987) ‘Phaclofen: a peripheral and central baclofen antagonist’, Brain Res. 405: 150-154.
91. Kiuchi, Y., Kobayashi, T., Takeuchi, J., Shimuzu, H., Ogata, H. and Toru, M. (1989) ‘Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics’, Eur. Arch. Psychiat. Neurol. Sci. 239: 71-78.
92. Kjaer, M. and Nielsen, H. (1983) ‘The analgesic action of the GABA agonist THIP in patients with chronic pain of malignant origin’, Br. J. Clin. Pharmacol. 16: 477-485.
93. 3H]Ro 15-4513 binding sites’, Eur. J. Pharmacol. 213: 323-329.
94. Korsgaard, S., Casey, D.E., Gerlach, J., Hetmar, O., Kaldan, B. and Mikkelsen, L.B. (1982) ‘The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia’, Arch. Gen. Psychiatry 39: 1017-1021.
95. B receptor antagonists: stereostructure - activity relationships’, J. Neurochem. 58: 1150-1159.
96. A receptor ligand, 4-PIOL, on cultured hippocampal neurons’, Br. J. Pharmacol. 104: 85-90.
97. Krnjevic, K. (1974) ‘Chemical nature of synaptic transmission in vertebrates’, Physiol. Rev. 54: 418-540.
98. Krogsgaard-Larsen, P. (1988) ‘GABA synaptic mechanisms: stereochemical and conformational requirements’, Med. Res. Rev. 8: 27-56.
99. Krogsgaard-Larsen, P., Falch, E. and Christensen, A.V. (1984) ‘Chemistry and pharmacology of the GABA agonists THIP (gaboxadol) and isoguvacine’, Drugs Fut. 9: 597-618.
100. Krogsgaard-Larsen, P., Falch, E. and Hjeds, H. (1985) ‘Heterocyclic analogues of GABA: chemistry, molecular pharmacology and therapeutic aspects’, Prog. Med. Chem. 22: 67-120.
101. Krogsgaard-Larsen, P., Falch, E., Larsson, O.M. and Schousboe, A. (1987) ‘GABA uptake inhibitors: relevans to antiepileptic drug research’, Epilepsy Res. 1: 77-93.
102. Krogsgaard-Larsen, P., Falch, E., Schousboe, A., Curtis, D.R. and Lodge, D. (1980a) ‘Piperidine-4- sulphonic acid, a new specific GABA agonist’, J. Neurochem. 34: 756-759.
103. Krogsgaard-Larsen, P., Frølund, B. and Frydenvang, K. (2000) ‘GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects’, Curr. Pharm. Des. 6: 1193-1209.
104. A receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects’, J. Med. Chem. 37: 2489-2505.
105. B receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects’, Eur. J. Pharm. Sci. 5: 355-384.
106. Krogsgaard-Larsen, P. and Hansen, J.J. (eds) (1992) Excitatory Amino Acid Receptors: Design of Agonists and Antagonists, Chichester: Ellis Horwood.
107. Krogsgaard-Larsen, P., Hjeds, H., Curtis, D.R., Lodge, D. and Johnston, G.A.R. (1979) ‘Dihydromuscimol, thiomuscimol and related heterocyclic compounds as GABA analogues’, J. Neurochem. 32: 1717-1724.
108. Krogsgaard-Larsen, P., Hjeds, H., Falch, E., Jørgensen, F.S. and Nielsen, L. (1988) ‘Recent advances in GABA agonists, antagonists and uptake inhibitors: structure-activity relationships and therapeutic potential’, Adv. Drug Res. 17: 381-456.
109. Krogsgaard-Larsen, P., Jacobsen, P., Brehm, L., Larsen, J.-J. and Schaumburg, K. (1980b) ‘GABA agonists and uptake inhibitors designed as agents with irreversible actions’, Eur. J. Med. Chem. 15: 529-535.
110. Krogsgaard-Larsen, P. and Johnston, G.A.R. (1975) ‘Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds’, J. Neurochem. 25: 797-802.
111. Krogsgaard-Larsen, P., Johnston, G.A.R., Lodge, D. and Curtis, D.R. (1977) ‘A new class of GABA agonist’, Nature 268: 53-55.
112. Krogsgaard-Larsen, P., Mikkelsen, H., Jacobsen, P., Falch, E., Curtis, D.R., Peet, M.J. and Leah, J.D. (1983) '4,5,6,7-tetrahydroisothiazolo[5,4-c]pyridin-3-ol and related analogues of THIP. Synthesis and biological activity’, J. Med. Chem. 26: 895-900.
113. Krogsgaard-Larsen, P., Nielsen, L., Falch, E. and Curtis, D.R. (1986) ‘GABA agonists. Resolution, absolute stereochemistry, and enantioselectivity of (S)-(+)- and (R)-(-)-dihydromuscimol’, J. Med. Chem. 28: 1612-1617.
114. 3H]piperidine-4-sulfonic acid to bovine brain synaptic membranes’, J. Neurochem. 37: 401-409.
115. A receptor function’, Trends Pharmacol. Sci. 16: 295-303.
116. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat’, NeuroReport 7: 2241-2245.
117. Levi, G. and Gallo, V. (1981) ‘Glutamate as a putative transmitter in the cerebellum: stimulation by GABA of glutamic acid release from specific pools’, J. Neurochem. 37: 22-31.
118. Lodge, D. (ed.) (1988) Excitatory Amino Acids in Health and Disease, Chichester: John Wiley.
119. Lopez, I., Wu, J.Y. and Meza, G. (1992) ‘Immunocytochemical evidence for an afferent GABAergic neurotransmission in the guinea pig vestibular system’, Brain Res. 589: 341-348.
120. Löscher, W. (1989) ‘GABA and the epilepsies. Experimental and clinical conditions’, in N.G. Bowery and G. Nistico (eds) GABA: Basic Research and Clinical Applications, Rome: Pythagora Press, pp. 260-300.
121. A receptor selective for a behavioural alcohol antagonist’, Nature 346: 648-651.
122. A receptor channels’, Annu. Rev. Neurosci. 17: 569-602.
123. Maksay, G. (1994) ‘Thermodynamics of -γ-aminobutyric acid type A receptor binding differentiate agonists from antagonists’, Mol. Pharmacol. 46: 386-390.
124. B receptors and antagonism by CGP 35348 prevent bicuculline- and picrotoxininduced antinociception’, Neuropharmacology 31: 783-791.
125. 3H]Ro 15-4513 binding in intact cultured cerebellar granule cells’, Eur. J. Pharmacol. 169: 53-60.
126. BR1', Mol. Cell Neurosci. 13: 180-191.
127. A receptor: new insights from single-channel recording’, Synapse 1: 96-101.
128. A receptors’, Drug News & Perspect. 5: 145-152.
129. Meier, E., Drejer, J. and Schousboe, A. (1984) ‘GABA induces functionally active low-affinity GABA receptors on cultured cerebellar granule cells’, J. Neurochem. 43: 1737-1744.
130. Meldrum, B. (1982) ‘GABA and acute psychoses’, Psychol. Med. 12: 1-5.
131. Melikian, A., Schlewer, G., Chambon, J.-P. and Wermuth, C.G. (1992) ‘Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists’, J. Med. Chem. 35: 4092-4097.
132. Merz, W.A., Alterwain, P., Ballmer, U., Bechelli, L., Capponi, R., Munoz, J.G., Marquez, C., Nestoros, J., Almanzor, L.R., Udabe, R.U. and Versiani, M. (1988) ‘Treatment of paranoid schizophrenia with the partial benzodiazepine agonist, Ro 16-6028', Psychopharmacol. Suppl. 237: 95-96.
133. A-like autoreceptor is a pharmacologically novel GABA receptor’, in G. Biggio, A. Concas and E. Costa (eds) GABAergic Synaptic Transmission, New York: Raven Press, pp. 199-203.
134. Minchin, M.C.W., White, A.C. and White, J.F. (1992b) ‘Novel GABA autoreceptor antagonists’, Current Drugs 2: 1878-1880.
135. Mitchell, R. (1980) ‘A novel GABA receptor modulates stimulus induced glutamate release from cortico-striatal terminals’, Eur. J. Pharmacol. 67: 119-122.
136. B receptors make it to the top - as dimers’, Trends. Pharmacol. Sci. 20: 87-89.
137. A-receptors: cell-specific expression, pharmacology, and regulation’, Neurochem. Res. 20: 631-636.
138. Möhler, H. and Okada, T. (1977) ‘Benzodiazepine receptors: demonstration in the central nervous system’, Science 198: 849-851.
139. Monaghan, D.T. and Wenthold, R.J. (1997) The Ionotropic Glutamate Receptors, Totowa, N.J.: Humana Press.
140. Morselli, P.L., Löscher, W., Lloyd, K.G., Meldrum, B. and Reynolds, E.H. (eds) (1981) Neurotransmitters, Seizures, and Epilepsy, New York: Raven Press.
141. C receptor’, Bioorg. Med. Chem. Lett. 6: 2073-2076.
142. A receptor determined by electron microscopic image analysis’, J. Neurochem. 62: 815-818.
143. 3H]aspartate from rat hippocampus monitored by intracerebral microdialysis’, Neurochem. Res. 14: 321-326.
144. Nielsen, L., Brehm, L. and Krogsgaard-Larsen, P. (1990) ‘GABA agonists and uptake inhibitors. Synthesis, absolute stereochemistry, and enantioselectivity of (R)-(-)- and (S)-(+)-homo-β-proline’, J. Med. Chem. 33: 71-77.
145. A receptor’, Eur. J. Pharmacol. 289: 109-112.
146. Nistico, G., Morselli, P.L., Lloyd, K.G., Fariello, R.G. and Engel, J. (eds) (1986) Neurotransmitters, Seizures, and Epilepsy III, New York: Raven Press.
147. A receptor family in the mammalian brain’, Neurochem. Res. 16: 317-325.
148. A receptors’, FASEB J. 4: 1469-1480.
149. Olsen, R.W. and Venter, J.C. (eds) (1986) Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, New York: Alan R. Liss.
150. Ong, J. and Kerr, D.I.B. (1990) ‘GABA-receptors in peripheral tissues’, Life Sci. 46: 1489-1501.
151. A antagonist in the guinea-pig isolated ileum’, J. Pharm. Pharmacol. 42: 662-664.
152. A- receptor-complexes in the guinea-pig isolated ileum’, Neurosci. Lett. 82: 101-106.
153. Palay, S. and Chan-Palay, V. (1982) ‘The cerebellum - new vistas’, Exp. Brain Res., 6 (suppl.): 1-620.
154. Petersen, H.R., Jensen, I. and Dam, M. (1983) ‘THIP: a single-blind controlled trial in patients with epilepsy’, Acta Neurol. Scand. 67: 114-117.
155. A receptors activation’, Epilepsy Res. 19: 45-54.
156. A agonist administration in TLE’, Epilepsy Res. 19: 55-62.
157. A receptors’, Neuropharmacology 32: 59-63.
158. Qian, H. and Dowling, J.E. (1993a) ‘GABA responses on retinal bipolar cells’, Biol. Bull., 185: 312.
159. Qian, H. and Dowling, J.E. (1993b) ‘Novel GABA responses from roddriven retinal horizontal cells’, Nature 361: 162-164.
160. Qian, H. and Dowling, J.E. (1994) ‘Pharmacology of novel GABA receptors found on rod horizontal cells of the white perch retina’, J. Neurosci. 14: 4299-4307.
161. Redburn, D.A. and Schousboe, A. (eds) (1987) Neurotrophic Activity of GABA during Development, New York: Alan R. Liss.
162. Ring, H.A. and Reynolds, E.H. (1990) ‘Vigabatrin and behaviour disturbance’, Lancet 335: 970.
163. Roberts, E. (1976) ‘Disinhibition as an organizing principle in the nervous system - the role of the GABA system. Application to neurologic and psychiatric disorders’, in E. Roberts, T.N. Chase and D.B. Tower, (eds) GABA in Nervous System Function, New York: Raven Press, pp. 515-539.
164. Roberts, E. (1986) ‘GABA: The road to neurotransmitter status’, in R.W. Olsen. and J.C. Venter (eds) Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, New York: Alan R. Liss, pp. 1-39.
165. Roberts, E. (1991) ‘Living systems are tonically inhibited, autonomous optimizers, and disinhibition coupled to a variability generation is their major organizing principle: inhibitory command-control at levels of membrane, genome, metabolism, brain, and society’, Neurochem. Res. 16: 409-421.
166. Robinson, M.K., Richens, A. and Oxley, R. (1990) ‘Vigabatrin and behaviour disturbances’, Lancet 336: 504.
167. A receptor antagonists’, J. Med. Chem. 35: 1969-1977.
168. A agonist THIP on regional cortical blood flow in humans. A new test of hemispheric dominance’, J. Cereb. Blood Flow Metab. 8: 314-323.
169. A-receptor chloride channels’, Nature 341: 233-236.
170. Ryan, A.F. and Schwartz, I.R. (1986) ‘Nipecotic acid: preferential accumulation in the cochlea by GABA uptake systems and selective retrograde transport to brainstem’, Brain Res. 399: 399-403.
171. Saito, A., Wu, J.Y. and Lee, T.J. (1985) ‘Evidence for the presence of cholinergic nerves in cerebral arteries: an immunohistochemical demonstration of choline acetyltransferase’, J. Cereb. Blood Flow Metab. 5: 327-334.
172. Sander, J.W. and Hart, Y.M. (1990) ‘Vigabatrin and behaviour disturbances’, Lancet 335: 57.
173. Sawynok, J. (1989) ‘GABAergic agents as analgesics’, in N.G. Bowery and G. Nistico (eds) GABA: Basic Research and Clinical Applications, Rome: Pythagora Press, pp. 383-399.
174. B receptors: cerebellar granule cells as a model system’, Neurochem. Intl. 34: 373-377.
175. Schousboe, A., Diemer, N.H. and Kofod, H. (eds) (1992a) Drug Research Related to Neuroactive Amino Acids, Copenhagen: Munksgaard.
176. A receptors in glutamatergic neurons’, in P. Krogsgaard-Larsen, S.B. Christensen and H. Kofod (eds) New Leads and Targets in Drug Research, Copenhagen: Munksgaard, pp. 176-186.
177. Schousboe, A., Larsson, O.M., Hertz, L. and Krogsgaard-Larsen, P. (1981) ‘Heterocyclic GABA analogues as new selective inhibitors of astroglial GABA transport’, Drug Dev. Res. 1: 115-127.
178. Schousboe, A., Thorbek, P., Hertz, L. and Krogsgaard-Larsen, P. (1979) ‘Effects of GABA analogues of restricted conformation on GABA transport in astrocytes and brain cortex slices and on GABA receptor binding’, J. Neurochem. 33: 181-189.
179. A receptor complex after the in vivo administration of the anxioselective and anticonvulsant β-carboline derivative abecarnil’, J. Pharmacol. Exp. Ther. 263: 1360-1368.
180. Seutin, V. and Johnson, S.W. (1999) ‘Recent advances in the pharmacology of quaternary salts of bicuculline’, Trends. Pharmacol. Sci. 20: 268-270.
181. − ion channels modulated by multiple drugbinding sites’, Trends Pharmacol. Sci. 13: 446-450.
182. A receptor subtypes’, Pharmacol. Rev. 47: 181-234.
183. 3H]Ro 15-4513: a biochemical and autoradiographic study’, J. Neurochem. 48: 46-52.
184. A receptors’, Neurochem. Intl. 34: 379-385.
185. + channels’, Prog. Neurobiol. 36: 35-92.
186. A receptors’, Trends Pharmacol. Sci. 16: 162-169.
187. Solimena, M. and De Camilli, P. (1993) ‘Spotlight on a neuronal enzyme’, Nature, 366: 15-17.
188. Squires, R.F. and Braestrup, C. (1977) ‘Benzodiazepine receptors in rat brain’, Nature 266: 732-734.
189. 3H]flunitrazepam binding in cingulate cortex and hippocampus of post morten schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?', Neurochem. Res. 18: 219-223.
190. Squires, R.F. and Saedrup, E. (1991) ‘A review of evidence for GABAergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of “functional” psychosis’, Neurochem. Res. 16: 1099-1111.
191. A receptors’, in F.A. Stephenson and A.J. Turner (eds) Amino Acid Neurotransmission, London: Portland Press.
192. Stephenson, F.A. and Turner, A.J. (eds) (1998) Amino Acid Neurotransmission, London: Portland Press.
193. Stone, T.W. (1979) ‘Glutamate as the neurotransmitter of cerebellar granule cells in the rat: electro-physiological evidence’, Br. J. Pharmacol. 66: 291-296.
194. Supavilai, P. and Karobath, M. (1985) ‘Modulation of acetylcholine release from rat striatal slices by the GABA/benzodiazepine receptor complex’, Life Sci. 36: 417-426.
195. Sutch, R.J., Davies, C.C. and Bowery, N.G. (1999) ‘GABA release and uptake measured in crude synaptosomes from Genetic Absence Epilepsy Rats from Strasbourg (GAERS)', Neurochem. Intl. 34: 415-425.
196. Tallman, J.F., Paul, S.M., Skolnick, P. and Gallager, D.W. (1980) ‘Receptors for the age of anxiety: pharmacology of the benzodiazepines’, Science 207: 274-281.
197. Tamminga, C.A., Crayton, J.W. and Chase, T.N. (1978) ‘Muscimol: GABA agonist therapy in schizophrenia’, Am. J. Psychiat. 135: 746-747.
198. Tamminga, C.A., Crayton, J.W. and Chase, T.N. (1979) ‘Improvement of tardive dyskinesia after muscimol therapy’, Arch. Gen. Psychiat. 36: 595-598.
199. Tanaka, C. and Bowery, N.G. (1996) GABA: Receptors, Transporters and Metabolism, Basel: Birkhäuser Verlag.
200. Thaker, G.K., Hare, T.A. and Tamminga, C.A. (1983) ‘GABA system: clinical research and treatment of tardive dyskinesia’, Mod. Probl. Pharmacopsychiat. 21: 155-167.
201. Thaker, G.K., Nguyen, J.A. and Tamminga, C.A. (1989) ‘Increased saccadic distractability in tardive dyskinesia: functional evidence for subcortical GABA dysfunction’, Biol. Psychiatry 25: 49-59.
202. Theobald, W., Buch, O., Kunz, H.A., Krupp, P., Stenger, E.G. and Heimann, H. (1968) ‘Pharmakologische und experimentalpsychologische untersuchungen mit 2 inhaltsstoffen des fliegenpilzes (Amanita Muscaria)', Arzneim. Forsch. 18: 311-315.
203. Tirsch, R., Yang, X.-D., Singer, S.M., Liblau, R.S., Fugger, L. and McDevitt, H.O. (1993) ‘Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice’, Nature 366: 72-75.
204. Travagli, R.A., Ulivi, M. and Wojcik, W.J. (1991) '-y-aminobutyric acid-B receptors inhibit glutamate release from cerebellar granule cells: consequences of inhibiting cyclic AMP formation and calcium influx’, J. Pharm. Exp. Ther. 258: 903-909.
205. Usami, S., Hozawa, J., Tazawa, M., Igarashi, M., Thompson, G.C., Wu, J.Y. and Wenthold, R.J. (1989) ‘Immunocytochemical study of the GABA system in chicken vestibular endorgans and the vestibular ganglion’, Brain Res. 503: 214-218.
206. Van Ness, P.C., Watkins, A.E., Bergman, M.O., Tourtelotte, W.W. and Olsen, R.W. (1982) 'γ-yaminobutyric acid receptors in normal human brain and Huntington’s disease’, Neurology 32: 63-68.
207. Venault, P., Chapouthier, G., Prado de Carvalho, L., Simiand, J., Morre, M., Dodd, R.H. and Rossier, J. (1986) ‘Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks’, Nature 321: 864-866.
208. A receptors depend upon subunit composition’, Neuron 4: 919-928.
209. A-type receptors and activation of chloride and voltage-sensitive calcium channels’, Endocrinology 126: 2499-2505.
210. A receptors, and glutamate receptors develop sequentially on embryonic rat spinal cord cells’, J. Neurosci. 13: 2068-2084.
211. A antagonists’, Trends Pharmacol. Sci. 7: 421-424.
212. Wermuth, C.G., Bourguignon, J.-J., Schlewer, G., Gies, J.-P., Schoenfelder, A., Melikian, A., Bouchet, M.-J., Chantreux, D., Molimard, J.-C., Heaulme, M., Chambon, J.-P. and Biziére, K. (1987) ‘Synthesis and structure-activity relationships of a series of aminopyridazine derivatives of -γ-aminobutyric acid acting as selective GABA-A antagonists’, J. Med. Chem. 30: 239-249.
213. Wheal, H. and Thomson, A. (eds) (1995) Excitatory Amino Acids and Synaptic Transmission, London: Academic Press.
214. A receptor gene family: new targets for therapeutic intervention’, Neurochem. Intl. 34: 387-390.
215. A receptors is essential for benzodiazepine agonist binding’, J. Biol. Chem. 267: 1426-1429.
216. Williams, M., Kowaluk, E.A. and Arneric, S.P. (1999) ‘Emerging molecular approaches to pain therapy’, J. Med. Chem., 42: 1481-1500.
217. B receptor agonists and antagonists’, Mol. Pharmacol. 43: 609-625.
218. Wurtman, R.J., Corkin, S., Growdon, J.H. and Ritter-Walker, E. (eds) (1990) Advances in Neurology. Vol. 51. Alzheimer’s Disease, New York: Raven Press.
219. A receptors’, J. Med. Chem. 38: 1679-1688.
220. Zorn, S.H. and Enna, S.J. (1987) ‘The GABA agonist THIP attenuates antinociception in the mouse by modifying central cholinergic transmission’, Neuropharmacology 26: 433-437.